Last reviewed · How we verify
Lac-Hydrin (AMMONIUM LACTATE)
Lac-Hydrin (generic name: AMMONIUM LACTATE) is a alpha-Hydroxy Acid [EPC] Small molecule drug developed by Sun Pharma. It is currently FDA-approved (first approved 1985) for Ichthyosis vulgaris, Xerosis.
Lac-Hydrin is a lactated ringers solution used in aggressive intravenous hydration. It is studied in ClinicalTrials.gov for conditions such as pancreatitis, pancreatic duct stones, and hypotension.
At a glance
| Generic name | AMMONIUM LACTATE |
|---|---|
| Sponsor | Sun Pharma |
| Drug class | alpha-Hydroxy Acid [EPC] |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 1985 |
Approved indications
- Ichthyosis vulgaris
- Xerosis
Common side effects
- rash (including erythema and irritation)
- burning/stinging
- itching
- transient burning
- stinging
- dry skin
- rash
Key clinical trials
- Effects of Carnitine Supplementation on Exercise-Induced Muscle Damage: A Randomized Controlled Trial (NA)
- Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial (NA)
- Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial) (NA)
- Repeated Examinations for Typing Pulmonary Embolism
- Evaluating Prognostic Contribution of Lactate on Recovery of Spontaneous Cardiac Activity After Cardiac Arrest (NA)
- Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery (PHASE1)
- Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy (PHASE2)
- Evaluation of Intravenous Sodium Valproate on Interleukin-6 Levels in Patients With TMJ Disc Displacement (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lac-Hydrin CI brief — competitive landscape report
- Lac-Hydrin updates RSS · CI watch RSS
- Sun Pharma portfolio CI
Frequently asked questions about Lac-Hydrin
What is Lac-Hydrin?
What is Lac-Hydrin used for?
Who makes Lac-Hydrin?
What is the generic name of Lac-Hydrin?
What drug class is Lac-Hydrin in?
When was Lac-Hydrin approved?
What development phase is Lac-Hydrin in?
What are the side effects of Lac-Hydrin?
Related
- Drug class: All alpha-Hydroxy Acid [EPC] drugs
- Manufacturer: Sun Pharma — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Ichthyosis vulgaris
- Indication: Drugs for Xerosis
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing